JP2004502720A5 - - Google Patents

Download PDF

Info

Publication number
JP2004502720A5
JP2004502720A5 JP2002508415A JP2002508415A JP2004502720A5 JP 2004502720 A5 JP2004502720 A5 JP 2004502720A5 JP 2002508415 A JP2002508415 A JP 2002508415A JP 2002508415 A JP2002508415 A JP 2002508415A JP 2004502720 A5 JP2004502720 A5 JP 2004502720A5
Authority
JP
Japan
Prior art keywords
particulate carrier
carrier according
polymer
poly
particulate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002508415A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004502720A (ja
JP5175017B2 (ja
Filing date
Publication date
Priority claimed from FR0008902A external-priority patent/FR2811227A1/fr
Application filed filed Critical
Publication of JP2004502720A publication Critical patent/JP2004502720A/ja
Publication of JP2004502720A5 publication Critical patent/JP2004502720A5/ja
Application granted granted Critical
Publication of JP5175017B2 publication Critical patent/JP5175017B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002508415A 2000-07-07 2001-07-05 有効成分の経口吸収を改善するための粒子状担体 Expired - Fee Related JP5175017B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0008902A FR2811227A1 (fr) 2000-07-07 2000-07-07 Vecteurs particulaires destines a ameliorer l'absorption orale de principes actifs
FR00/08902 2000-07-07
PCT/FR2001/002159 WO2002003960A1 (fr) 2000-07-07 2001-07-05 Vecteurs particulaires destines a ameliorer l'absorption orale de principes actifs

Publications (3)

Publication Number Publication Date
JP2004502720A JP2004502720A (ja) 2004-01-29
JP2004502720A5 true JP2004502720A5 (cg-RX-API-DMAC7.html) 2008-01-24
JP5175017B2 JP5175017B2 (ja) 2013-04-03

Family

ID=8852251

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002508415A Expired - Fee Related JP5175017B2 (ja) 2000-07-07 2001-07-05 有効成分の経口吸収を改善するための粒子状担体

Country Status (17)

Country Link
US (1) US8052998B2 (cg-RX-API-DMAC7.html)
EP (1) EP1313453B1 (cg-RX-API-DMAC7.html)
JP (1) JP5175017B2 (cg-RX-API-DMAC7.html)
KR (1) KR20030038655A (cg-RX-API-DMAC7.html)
CN (1) CN1440277A (cg-RX-API-DMAC7.html)
AT (1) ATE395906T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002218745A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0112080B1 (cg-RX-API-DMAC7.html)
CA (1) CA2415414C (cg-RX-API-DMAC7.html)
DE (1) DE60134147D1 (cg-RX-API-DMAC7.html)
DK (1) DK1313453T3 (cg-RX-API-DMAC7.html)
ES (1) ES2305121T3 (cg-RX-API-DMAC7.html)
FR (1) FR2811227A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA03000193A (cg-RX-API-DMAC7.html)
PT (1) PT1313453E (cg-RX-API-DMAC7.html)
RU (1) RU2003103596A (cg-RX-API-DMAC7.html)
WO (1) WO2002003960A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8652504B2 (en) 2005-09-22 2014-02-18 Medivas, Llc Solid polymer delivery compositions and methods for use thereof

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2060253A1 (en) * 2007-11-14 2009-05-20 Laboratorios Farmaceuticos Rovi, S.A. Pharmaceutical forms for the release of active compounds
US8257744B2 (en) * 2000-07-07 2012-09-04 Laboratorios Farmacéuticos Rovi, S.A. Pharmaceutical forms for the release of active compounds
BE1015608A6 (fr) * 2003-07-15 2005-06-07 Messadek Jallal Traitement des arterites.
EP1615632B1 (fr) * 2003-04-17 2006-12-06 Jallal Messadek Formulations orales flottantes pour la liberation controlee de la betaine
US20060128657A1 (en) * 2003-08-04 2006-06-15 Jallal Messadek Selected betaines and their uses
WO2005095950A1 (en) * 2004-03-30 2005-10-13 Pfizer Products Inc. Method and device for evaluation of pharmaceutical compositions
BE1016128A6 (fr) * 2004-07-22 2006-03-07 Messadek Jallal Combinaisons therapeutiques
WO2006050581A2 (en) * 2004-11-10 2006-05-18 Jallal Messadek Betaine as agent against arthropod - or mosquito -borne diseases
CA2596011C (en) * 2005-02-17 2013-05-14 Medivas, Llc Polymer particle delivery compositions and methods of use
RU2007143510A (ru) * 2005-04-27 2009-06-10 Яллал МЕССАДЕК (BE) Инсулиновые композиции
WO2008065502A1 (en) * 2006-11-29 2008-06-05 Pfizer Products Inc. Pharmaceutical compositions based on a) nanoparticles comprising enteric polymers and b) casein
US20100119612A1 (en) * 2007-04-17 2010-05-13 Bend Research, Inc Nanoparticles comprising non-crystalline drug
US8703204B2 (en) * 2007-05-03 2014-04-22 Bend Research, Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
US20100080852A1 (en) * 2007-05-03 2010-04-01 Ronald Arthur Beyerinck Phamaceutical composition comprising nanoparticles and casein
WO2008135828A2 (en) * 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
EP2162120B1 (en) * 2007-06-04 2016-05-04 Bend Research, Inc Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
US20100215747A1 (en) * 2007-07-13 2010-08-26 Corey Jay Bloom Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
US8802156B2 (en) 2007-11-14 2014-08-12 Laboratorios Farmacéuticos Rovi, S.A. Pharmaceutical forms for the release of active compounds
EP2213282A1 (en) * 2009-01-30 2010-08-04 Laboratorios Farmaceuticos Rovi, S.A. Pharmaceutical forms for the release of active compounds
WO2009065193A1 (en) * 2007-11-21 2009-05-28 Jallal Messadek Treatment of aspirin resistance with betaine and/or betaine enriched molasses
EP2240162A4 (en) * 2007-12-06 2013-10-09 Bend Res Inc NANOTE PARTICLES WITH A NON-IONIZABLE POLYMER AND AN AMIN-FUNCTIONALIZED METHACRYLATE COPOLYMER
WO2009073215A1 (en) * 2007-12-06 2009-06-11 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
US9101547B2 (en) * 2011-08-04 2015-08-11 Nano And Advanced Materials Institute Limited Enteric-coated capsule containing cationic nanoparticles for oral insulin delivery
DE102012019029A1 (de) 2012-09-27 2014-03-27 Alf Lamprecht Arzneiformulierungen zur oralen Gabe von therapeutischen Substanzen und Verfahren zur Herstellung
US10398655B2 (en) 2016-02-18 2019-09-03 Privo Technologies, Inc. Two-stage microparticle-based therapeutic delivery system and method
US20180235899A1 (en) 2017-02-17 2018-08-23 Privo Technologies, Inc. Particle-based multi-layer therapeutic delivery device and method
US10478403B1 (en) 2017-05-03 2019-11-19 Privo Technologies, Inc. Intraoperative topically-applied non-implantable rapid release patch
KR20240041285A (ko) 2021-06-01 2024-03-29 프리보 테크놀로지스, 인코포레이티드 향상된 2단계 미세입자 기반 국소 치료제 전달 시스템

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT397345B (de) * 1990-04-04 1994-03-25 Chemiefaser Lenzing Ag Pharmazeutisches präparat mit verzögerter wirkstofffreisetzung auf basis von hemicellulosen
AU653771B2 (en) * 1991-01-03 1994-10-13 Alkermes Controlled Therapeutics, Inc. Stabilization of proteins by cationic biopolymers
KR100259989B1 (ko) * 1991-10-01 2000-08-01 모리다 가쓰라 서방성 마이크로캡슐 제제 및 그의 제조법
GB9202464D0 (en) * 1992-02-05 1992-03-18 Danbiosyst Uk Composition for nasal administration
DE4220782A1 (de) * 1992-06-25 1994-01-05 Basf Ag Verfahren zur Herstellung von festen pharmazeutischen Retardformen
US5401516A (en) * 1992-12-21 1995-03-28 Emisphere Technologies, Inc. Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
GB9412273D0 (en) * 1994-06-18 1994-08-10 Univ Nottingham Administration means
US6346274B1 (en) * 1995-03-10 2002-02-12 Roche Diagnostics Gmbh Polypeptide-containing pharmaceutical forms of administration in the form of microparticles and method for the preparation thereof
US5686113A (en) * 1995-03-21 1997-11-11 Temple University Of The Commonwealth System Of Higher Education Microcapsules of predetermined peptide(s) specificity (ies), their preparation and uses
FR2769853B1 (fr) * 1997-10-21 2000-01-28 Prographarm Lab Nouveau procede d'obtention de microspheres et les produits ainsi realises
WO2000028989A1 (en) * 1998-11-12 2000-05-25 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
AU3471400A (en) * 1999-01-19 2000-08-07 Children's Hospital Of Philadelphia, The Compositions and methods for controlled delivery of virus vectors

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8652504B2 (en) 2005-09-22 2014-02-18 Medivas, Llc Solid polymer delivery compositions and methods for use thereof

Similar Documents

Publication Publication Date Title
US6395302B1 (en) Method for the preparation of microspheres which contain colloidal systems
CA2126685C (en) Process for the production of microcapsules
CA2709712C (en) Process for preparing microparticles having a low residual solvent volume
RU2003103596A (ru) Носитель в виде частиц, предназначенный для улучшения перорального всасывания активных начал
JP2005510521A5 (cg-RX-API-DMAC7.html)
JP2002536317A (ja) ヒドロゲル粒子処方物
US20100173005A1 (en) Microparticle formulations for sustained-release of bioactive compounds
CN101094658A (zh) 用于改进释放至少一种活性成分的多微囊形式的口服药剂
JP4918212B2 (ja) 徐放性軟カプセル剤用の液体組成物およびこれらの製造方法
EP1370245B1 (en) Method to prepare microparticles containing metoprolol
ES2975989T3 (es) Composiciones de micropartículas inyectables de naltrexona de acción prolongada
AU2002235102A1 (en) Method to prepare microparticles that contain metoprolol
AU770235B2 (en) Delivery of microparticle formulations using needleless syringe device for sustained-release of bioactive compounds
JP2024507528A5 (cg-RX-API-DMAC7.html)
Sailaja et al. Approaches to creating and past successful attempts on microspheres: A primer for aspiring researchers
CN100400032C (zh) 一种油溶性药物缓释微球的制备方法
CN104825399B (zh) 包载康普瑞丁磷酸二钠的反胶束-微球缓释制剂及其制备方法
Vijayakumar et al. Drug carriers, polymers as: Synthesis, characterization, and in vitro evaluation
Kakad et al. Insight into Suitable Polymers and Materials for the Preparation of Novel Drug Delivery Systems
Comolli et al. Polymeric microparticles
Hennink et al. Molecular design of biodegradable dextran hydrogels for the controlled release of proteins
Patil et al. Microstructured Polymer System and Its Application in Pharmacy
Das et al. Development of Biodegradable Polymeric Nanoparticles for Systemic Delivery
Schmitt et al. Biodegradable polymers for the controlled delivery of vaccines
Schmitt et al. Iowa City, Iowa 52242